About this trial
The clinical performance of a bioactive composite (alkasite-based), a nanohybrid resin composite and a bulk-fill resin composite in class II restorations will be evaluated and compared. After recruiting participants with at least 3 approximal caries lesions, all restorations will be placed by a single clinician. All caries lesions will be removed before restoring. Cavities will be divided into three groups: a bioactive composite \[Cention Forte Ivoclar Vivadent, Schaan, Liechtenstein\], a nanohybrid resin composite \[Tetric N-Ceram2 (Ivoclar Vivadent, Schaan, Liechtenstein)\] and a bulk-fill resin composite \[Tetric N-PowerFill2 (Ivoclar Vivadent, Schaan, Liechtenstein)\], All restorative procedures will be conducted according to manufacturers' instructions. Restorations will be scored using FDI criteria after a week (baseline) 6, 12, 24, 36 and 48 months. Descriptive statistics will be performed using chi-square tests.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
age range will be 18 to 65
patients should have at least 3 approximal caries lesions require restoration
healthy periodontal status
a good likelihood of recall availability
Disqualifiers
poor gingival health
adverse medical history
potential behavioral problems
Trial design
Parallel
Treatments tested in this trial
bioactive composite
Devicebioactive composite restoration
nanohybrid resin composite
Devicenanohybrid resin composite restoration
bulk-fill resin composite
Devicebulk-fill resin composite restoration
Treatment groups
Trial outcomes
Primary outcomes
Clinical performances of different restorative systems according to FDI criteria
Two year results according to FDI criteria (scores 1-5, 1-very good, 5-poor/replace)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: